Meeting Banner
Abstract #3478

Quantification of Response of Hepatocellular Carcinoma(HCC) to Bevacizumab by Contrast Enhanced MRI

Mandeli J, Lehrer D, Cohen E, Schwartz J
Mount Sinai Medical Center

Quantiative assessment of effects of an anti-angiogenic agent on hepatocellular carcinoma by conrtast enhanced MRI demonstrating good correlation between change in size and degree of change in contrast enhancement.